Exploring the Therapeutic Potential of Animal Venoms
Introduction to Venomic Research
A recent review published in Toxicon delves into the unique properties of animal venoms and their promising applications as therapeutic agents. While creatures like snakes, scorpions, and spiders often evoke fear due to their venomous bites, ongoing research reveals that certain venoms may provide significant medical benefits. The field of “venomic” research is yielding potential drug candidates aimed at treating various human diseases.
Current Applications of Venom-Derived Drugs
There are currently over half a dozen FDA-approved drugs derived from animal venoms, which are utilized for conditions such as high blood pressure, pain management, and diabetes. The review, conducted by research institutes from Australia and Spain, focuses on the immunomodulatory properties of these venoms and their potential for enhancing or suppressing immune responses for therapeutic use.
The Immune Response to Animal Venom
Immediate Reactions to Venom Bites
When a venomous animal bites, the immune system reacts swiftly to counteract the venom’s effects. The initial response involves inflammation, an innate immune mechanism that alters blood flow, recruits immune cells—including neutrophils, mast cells, and macrophages—and triggers the release of inflammatory cytokines such as histamine, prostaglandins, and bradykinins. Together, these responses work to eliminate venom-affected tissues and mitigate the impact of the bite. Subsequently, adaptive immunity engages through T cells and B cells to further combat the adverse effects of the venom.
Understanding Snake Venoms
Composition and Therapeutic Benefits
Snake venoms, produced by specialized glands typically located beneath the eyes, are complex mixtures of enzymes, amino acids, carbohydrates, lipids, and metal ions. The protein composition of snake venom varies based on factors like diet, geographical location, age, and gender. Although all venoms activate immune responses, the specific mechanisms triggered can differ among various snake species.
Research into snake venoms has led to the development of significant therapeutic drugs. Notable examples include Capoten, Aggrastat, and Integrillin, which are derived from viper snakes and are used to treat hypertension and myocardial infarction. These medications function by inhibiting platelet aggregation or decreasing clot formation through interactions with enzymes in the clotting pathway.
Venoms from Scorpions, Bees, and Sea Anemones
Scorpion Venom and Immune Modulation
Scorpion venom interacts with various ion channels on nerve and immune cells, with some venoms exhibiting specificity for certain immune cell types. For instance, potassium ion channels on T cells are critical targets for modulating immune responses. The authors of the review propose that further investigation into the effects of scorpion venoms on potassium channels could provide insights into enhancing T cell activity. Additionally, specific scorpion venoms may stimulate the release of immune cells such as dendritic cells, which play a vital role in activating T cells.
Bee Venom and Its Immunotherapeutic Potential
Bee venom contains a high concentration of the peptide melittin, which promotes dendritic cell maturation and stimulates T cell activity. Many current immunotherapeutic drugs are designed to enhance T cell responses or facilitate antigen presentation through dendritic cells.
Sea Anemone Venoms
The Shk peptide from sea anemones serves as a selective immunosuppressive agent. Notably, Dalazatide, a peptide derived from sea anemones, has shown promise in a phase-1 clinical trial for treating psoriasis, an autoimmune skin disorder.
Other Notable Venom-Derived Drugs
Additional examples of medications derived from animal venoms include Angiomax (Bivalirudin, from leeches, used as an anticoagulant), Prialt (Ziconotide, from cone snails, for neuropathic pain), and Bydureon (Exenatide, from Gila monsters, for managing type 2 diabetes).
Conclusion
Despite the inherent toxicity of animal venoms, ongoing research is essential to establish their efficacy and tolerability as potential therapeutic agents.
Written by Vinayak Khattar, Ph.D., M.B.A.
Reference: Jimenez R, Ikonomopoulou MP, Lopez JA, Miles JJ. Immune drug discovery from venoms. Toxicon 141 (2018) 18-24.